REASONS FOR DISCONTINUATION OF TNF INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS ACCORDING TO DRUG HISTORY

被引：0
|
作者：
Matianova, E. [1 ]
Gordeev, A. [1 ]
Galushko, E. [1 ]
机构：
[1] VA Nasonova Rheumatol Res Inst, Rheumatoid Arthritis Evolut Lab, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2354
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0346
引用
收藏
页码：1298 / 1299
页数：2
相关论文
共 50 条
  • [21] Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
    Novella-Navarro, Marta
    Balsa, Alejandro
    DRUGS & AGING, 2022, 39 (11) : 841 - 849
  • [22] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
    Siebert, Stefan
    Marzo-Ortega, Helena
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (03) : 135 - 136
  • [23] Discontinuation of TNFα inhibitors in rheumatoid arthritis and psoriatic arthritis
    Oskarsdottir, Thorunn
    Gunnarsdottir, Anna Ingibjorg
    Gudbjornsson, Bjorn
    Gunnarsson, Petur Sigurdur
    Love, Thorvardur
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 182 - 183
  • [24] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
    Stefan Siebert
    Helena Marzo-Ortega
    Nature Reviews Rheumatology, 2024, 20 : 135 - 136
  • [25] Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
    Qi, Wen
    Robert, Antoine
    Singbo, Narcisse
    Ratelle, Lucie
    Fortin, Paul R.
    Bessette, Louis
    Brown, Jacques P.
    Michou, Laetitia
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01):
  • [26] Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
    Marta Novella-Navarro
    Alejandro Balsa
    Drugs & Aging, 2022, 39 : 841 - 849
  • [27] Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
    Ochi, Sae
    Sonomoto, Koshiro
    Nakayamada, Shingo
    Tanaka, Yoshiya
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [28] Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
    Sae Ochi
    Koshiro Sonomoto
    Shingo Nakayamada
    Yoshiya Tanaka
    Arthritis Research & Therapy, 24
  • [29] A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
    Novella-Navarro, M.
    Ruiz-Esquide, V.
    Torres-Ortiz, G.
    Chacur, C. A.
    Tornero, C.
    Fernandez-Fernandez, E.
    Monjo, I.
    Sanmarti, R.
    Plasencia-Rodriguez, C.
    Balsa, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (05) : 1114 - 1119
  • [30] Characteristics of Difficult-to-Treat Rheumatoid Arthritis: Results of an International Survey
    Roodenrijs, Nadia M. T.
    de Hair, Maria J. H.
    van der Goes, Marlies C.
    Jacobs, Johannes W. G.
    Welsing, Paco M. J.
    van der Heijde, Desiree
    Aletaha, Daniel
    Dougados, Maxime
    Hyrich, Kimme L.
    McInnes, Iain B.
    Mueller-Ladner, Ulf
    Senolt, Ladislav
    Szekanecz, Zoltan
    van Laar, Jacob
    Nagy, Gyorgy
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345